About the Product

Description


Olahype 2.5 Tablet contains Olanzapine 2.5mg, a well-established atypical antipsychotic used for the treatment of schizophrenia, bipolar disorder, and other psychotic illnesses. It works by balancing neurotransmitters in the brain, helping reduce hallucinations, mood instability, and thought disturbances.

The 2.5mg strength is often prescribed for dose initiation, elderly patients, or individuals sensitive to antipsychotic medications. Its predictable therapeutic response supports gradual symptom control with good tolerability under medical supervision.

Olanzapine tablets are widely prescribed in psychiatric clinics, mental health hospitals, and general medicine practices. The rising focus on mental health care has driven continuous demand for reliable antipsychotic therapies across healthcare systems.

Adding Olahype 2.5 Tablet to your psychiatry and mental-health segment strengthens your product portfolio and opens opportunities in pharmacy distribution, hospital procurement, institutional supplies, export markets, and third-party manufacturing. Its strong clinical relevance and steady prescription volume make it a commercially valuable psychiatric medicine.

Some patients may experience drowsiness, weight gain, increased appetite, dizziness, dry mouth, or constipation. Long-term use may cause metabolic changes such as increased blood sugar or lipid levels.

Olahype 2.5 Tablet is indicated for the treatment of schizophrenia, bipolar disorder (mania and maintenance therapy), and other psychotic disorders, as prescribed by a healthcare professional.

Use strictly under medical supervision. Do not discontinue abruptly. Regular monitoring of weight, blood sugar, and lipid profile is advised, especially during long-term therapy. Caution is required in elderly patients and those with diabetes or cardiovascular disorders.

Store Olahype 2.5 Tablet in a cool, dry place below 25°C, protected from light and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Olanzapine 2.5mg Tablet in the PCD pharma franchise market?

Olanzapine 2.5mg Tablet has steady demand in the psychiatry, neurology, and mental healthcare segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on central nervous system (CNS) and specialty care portfolios.

Why should medical distributors include Olanzapine 2.5mg Tablet in their product range?

Medical distributors and agencies can benefit from consistent demand for mental health disorder management under specialist medical supervision. Olanzapine 2.5mg is an atypical antipsychotic medication that helps regulate certain neurotransmitters in the brain Commonly prescribed for schizophrenia, bipolar disorder, and other psychiatric conditions as determined by healthcare professionals Helps manage symptoms such as mood disturbances, altered thinking patterns, and behavioral changes in eligible patients Frequently used as part of long-term psychiatric treatment plans under regular medical monitoring Widely prescribed by psychiatrists, neurologists, and mental health specialists This strengthens a comprehensive CNS and psychiatric care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Olanzapine 2.5mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from stable prescription demand, long-term therapy usage, repeat orders, reliable supply chain support, and attractive margins in the psychiatric care segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.